QT Medical, Inc.’s Post

Watch Michael Furman, MD, MS discuss C-arm adjustments for true lateral views in this clip from the #IPSISEducation Core Curriculum for Interventional Physicians: Radiofrequency Neurotomy video set — newly updated to include 3 new #InterventionalPainMedicine lectures on the sacroiliac joint and sacral lateral branch blocks and RF neurotomy. https://lnkd.in/grKYKzhy #PainMedicine #InterventionalPainManagement #PainManagement

GOOD WORK! Dr. Zola N'Dandu, Dr. Imraan Ansaarie Ansaarie and the team at ANSAARIE CARDIAC & ENDOVASCULAR CENTER OF EXCELLENCE in beautiful St. Augustine, FL completed their 2nd enrollment in the DEEPER REVEAL clinical trial (NCT05358353)!! The patient underwent successful treatment of the target lesion in the posterior tibial. The study is designed to evaluate the safety and efficacy of Reflow's Temporary Bare Spur Stent System (investigational use only). https://lnkd.in/gnJE2X4K #clinicaltrials #interventionalcardiology #clifighters #peripheralarterydisease #angiography #medicaldevices #cardiovasculardisease

💡 Did you know NHCS offers round the clock emergency coronary angioplasty for heart attack patients? Coronary angioplasty, also known as percutaneous coronary intervention, is a minimally invasive and non-surgical procedure used to open narrowed arteries to restore blood flow to the heart muscles. NHCS performs around 2,400 of coronary angioplasty and stenting procedures yearly with a skilled team of interventional cardiologists. #NHCSdidyouknow #Angioplasty

Exploring Cardiogenic Shock Treatment with Multi-Device Simulation #ComputationalLife In our latest breakthrough, we've digitally replicated a patient in the throes of cardiogenic shock to assess the efficacy of four distinct medical devices. Our visual graphs do more than just depict left ventricular volumes during a cardiac cycle – they provide critical insights that guide physicians towards the most impactful treatment options. The evidence is clear and corroborated by literature: ·      pVADs effectively reduce End-Diastolic Volume (EDV) without significantly affecting End-Systolic Volume (ESV). ·      IABP optimally decreases both EDV and ESV, improving cardiac function. ·      LVADs, with their unique triangular volume profiles, substantially reduce the overall volume in the left ventricle. ·      ECMO, specifically from the right atrium to the femoral artery, increases both ESV and EDV. These simulations are more than data – they are the future of personalized patient care, offering a window into the real-time impact of life-saving interventions. Delve into the intricacies of our pioneering research and be part of the conversation shaping the future of cardiac care. For continuous updates and insights, make sure to follow our LinkedIn page. #DigitalHealth #CardiogenicShock #MedicalSimulation #HealthcareInnovation #IABP #pVAD #LVAD #ECMO #CardiacCare"

Are you gearing up for #ACC24 tomorrow? Consider the ‘Power of One’— one vendor for your diagnostic cardiology needs, both inside and outside the hospital. Baxter’s diagnostic cardiology portfolio consists of resting and stress ECG devices, ambulatory monitoring and ECG management solutions designed to help simplify workflow and support informed clinical decisions for diagnosis and treatment.

My initial experience over the past 2 days (9 cases: 5 #PAF, 4 #PersAF) at HCA Florida Westside Hospital with the Boston Scientific Cardiology FARAPULSE, Inc. #PFA is that it can, from the onset, be safely and effectively utilized to isolate the PVs and the posterior wall employing an entirely fluoroless workflow with #ICE and 3D mapping with Abbott Ensite X. #epeeps #zerofluoro T.J. Lescher Brenna Metzler Katie Homeyer Image below: A: 3D map video showing flower configuration and 30 degree rotation B: 3D map video showing basket configuration and 30 degree rotation C: Pre/post map PVI PW isolation D: Post map WACA

Computational Life's simulation work on Cardiogenic Shock treatments showcases groundbreaking approaches to healthcare. Our insights into device efficacy illuminate paths to personalized care, proving how technology can transform patient outcomes. A fascinating glimpse into the power of medical simulations. #HealthTech #FutureOfMedicine

Exploring Cardiogenic Shock Treatment with Multi-Device Simulation #ComputationalLife In our latest breakthrough, we've digitally replicated a patient in the throes of cardiogenic shock to assess the efficacy of four distinct medical devices. Our visual graphs do more than just depict left ventricular volumes during a cardiac cycle – they provide critical insights that guide physicians towards the most impactful treatment options. The evidence is clear and corroborated by literature: pVADs effectively reduce End-Diastolic Volume (EDV) without significantly affecting End-Systolic Volume (ESV). IABP optimally decreases both EDV and ESV, improving cardiac function. LVADs, with their unique triangular volume profiles, substantially reduce the overall volume in the left ventricle. ECMO, specifically from the right atrium to the femoral artery, increases both ESV and EDV. These simulations are more than data – they are the future of personalized patient care, offering a window into the real-time impact of life-saving interventions. Delve into the intricacies of our pioneering research and be part of the conversation shaping the future of cardiac care. For continuous updates and insights, make sure to follow our LinkedIn page. #DigitalHealth #CardiogenicShock #MedicalSimulation #HealthcareInnovation #IABP #pVAD #LVAD #ECMO #CardiacCare

From awareness to action, physicians around the globe continue to research and advocate for cardiac care, leading to the improvement and advancement of treatments for diseases like Afib. Most recently, these advancements have led to LAAE being upgraded to a Class 1A recommendation by The Society of Thoracic Surgeons and as well as the Convergent procedure a Class 2B recommendation by ACC/AHA/ACCP/HRS guidelines. Thanks to physicians around the globe, we’re able to turn awareness into action. Learn more about the importance of treating Afib at: actagainstafib.com #Afib #HeartMonth

Exploring Cardiogenic Shock Treatment with Multi-Device Simulation #ComputationalLife In our latest breakthrough, we've digitally replicated a patient in the throes of cardiogenic shock to assess the efficacy of four distinct medical devices. Our visual graphs do more than just depict left ventricular volumes during a cardiac cycle – they provide critical insights that guide physicians towards the most impactful treatment options. The evidence is clear and corroborated by literature: pVADs effectively reduce End-Diastolic Volume (EDV) without significantly affecting End-Systolic Volume (ESV). IABP optimally decreases both EDV and ESV, improving cardiac function. LVADs, with their unique triangular volume profiles, substantially reduce the overall volume in the left ventricle. ECMO, specifically from the right atrium to the femoral artery, increases both ESV and EDV. These simulations are more than data – they are the future of personalized patient care, offering a window into the real-time impact of life-saving interventions. Delve into the intricacies of our pioneering research and be part of the conversation shaping the future of cardiac care. For continuous updates and insights, make sure to follow our LinkedIn page. #DigitalHealth #CardiogenicShock #MedicalSimulation #HealthcareInnovation #IABP #pVAD #LVAD #ECMO #CardiacCare